IMATINIB MESYLATE 400 MG TAB

What it is

IMATINIB MESYLATE 400 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “imatinib mesylate” and “imatinib”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Upsher-Smith Laboratories, LLC.

FDA’s Established Pharmacologic Class for it is Kinase Inhibitor.

The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 12 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $80.31 for 30 tablets (30 × $2.67707 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 12 labelers

When these prices took effect

• 2026-09-30 · 1 NDC · $2.67707 per EA filed
• 2026-09-23 · 14 NDCs · $2.67707 per EA filed

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with IMATINIB MESYLATE 400 MG TAB.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 15 NDCs’ NADAC prices is $2.67707 per EA filed.

Of the 20 other products in FDA’s Kinase Inhibitor class priced per EA, 15 have a higher middle NADAC price and 5 a lower one. The one in the middle is EVEROLIMUS 5 MG TABLET, at $14.77078 per EA filed (eff. 2026-04-22).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.